Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Ampal-American, Brainsway, Harel, Teva: Israeli Equity Preview

May 29 (Bloomberg) -- The following stocks may rise or fall in Israeli markets. Stock symbols are in parentheses after the company names and prices are from the last close unless otherwise stated.

The TA-25 Index rose 1.1 percent to 1,237.89 in Tel Aviv.

Ampal-American Israel Corp. (AMPL IT): The owner of a 12.5 percent stake in East Mediterranean Gas Co. said its series A, B and C bonds were lowered to Baa3 from Baa1 with a negative outlook and were removed from “watchlist” at Moody’s Midroog. Ampal-American gained 1.5 percent to 4.277 shekels.

Brainsway Ltd. (BRIN IT): The maker of devices expects to price a planned U.S. offering of 1 million shares at $9 to $11 each. The shares are being sold “together with” 667,000 warrants. Brainsway added 0.2 percent to 31.63 shekels.

Dexia Israel Bank Ltd. (DXIL IT): The mortgage lender said first-quarter profit rose to 9.8 million shekels ($2.8 million) from 9.2 million shekels a year earlier. Dexia advanced 2 percent to 652.40 shekels.

Hadera Paper Ltd. (HAP IT): The manufacturer of paper and paper products filed a shelf prospectus covering ordinary shares, debt securities and warrants. Hadera rose 4.3 percent to 246.10 shekels.

Harel Insurance Investments & Financial Services Ltd. (HARL IT): The insurer said first-quarter net income fell to 109.6 million shekels from 181.4 million shekels a year earlier. Harel increased 3 percent to 177.60 shekels.

Itamar Medical Ltd. (ITMR IT): The maker of medical-diagnostic equipment reported a first-quarter loss of $1.4 million after net income of $2 million a year ago. Itamar Medical increased 0.9 percent to 2.07 shekels.

Teva Pharmaceutical Industries Ltd. (TEVA IT): The U.S. Food and Drug Administration approved the world’s largest maker of generic drugs’ version of Viiv Healthcare Co.’s Combivir tablets to treat HIV. Teva fell 0.4 percent to 170.50 shekels.

To contact the reporter on this story: Sharon Wrobel in Tel Aviv at swrobel4@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.